CryoStasis will be presenting business updates and scientific results from our recently launched Early Access Program and select Investigator Initiated Studies.

Highlights from the ongoing collaboration between OHRI's BMC and CryoStasis presented at the 2024 Till & McCullouch Meeting

CryoStasis & UHN deliver compelling kidney transplant results for subzero unfrozen preservation technology

Exciting news in support of the CryoStasis mission

Describes the interdependency of corporate strategy and QMS

This article describes the relevance of a QMS for leading medical device companies

CryoStasis technology is based on the belief that stored biological material is best preserved by reducing its metabolic rate and ischemic interval.

What happens to the animals during hibernation at sub-zero temperatures? How can we explain the stories of people falling through the ice or being without oxygen for 30-45 minutes and fully recovering.

CryoStasis is excited to be highlighted at the Till & McCulloch conference in Vancouver, Oct 3rd to Oct 6th, 2022.